首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Immunotargets and therapy

缩写:

ISSN:N/A

e-ISSN:2253-1556

IF/分区:4.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引311
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Tianying Ma,Yanan Liu,Ying Zhu et al. Tianying Ma et al.
Background: Eculizumab had been approved for anti-acetylcholine receptor antibody-positive (AChR+) refractory myasthenia gravis (MG), but its effect on the broader group of highly active generalized myasthenia gravis (gMG...
Giulia Gualtiero,Helena Buso,Eva C Coopmans et al. Giulia Gualtiero et al.
Lymphoproliferation represents a common and clinically relevant feature across many Inborn Errors of Immunity (IEIs), reflecting the underlying immune dysregulation that characterizes these disorders. In affected individuals, lymphoprolifer...
Zixuan Cao,Shurong Tong,Zihan Wang et al. Zixuan Cao et al.
Glioblastoma (GBM) is the most aggressive malignant tumor affecting the central nervous system. Current standard of care provides only modest clinical benefits, most patients eventually develop tumor recurrence, at which point therapeutic o...
Yuming Xie,Yue Hu,Junke Huang et al. Yuming Xie et al.
Background: The expression of transient receptor potential vanilloid (TRPV) and Toll-like receptor 2 (TLR2) in the lesion sites of patients with rosacea is increased. Ultraviolet B (UVB) radiation can induce inflammation ...
Huiqiao Gu,Bingxin Hu,Yawen Jiang Huiqiao Gu
Purpose: Recurrent or metastatic cervical cancer (R/M CC) has limited therapeutic options after first-line treatment failure. Both enlonstobart and camrelizumab are anti-PD-1 antibodies recommended for second-line treatme...
Bo Li,Sitong Jiang,Fan Yang et al. Bo Li et al.
Although tumor immunotherapy has shown significant efficacy against solid tumors, it frequently causes cutaneous and follicular adverse events resulting from disruption of the hair follicle immune microenvironment. This microenvironment is ...
Sittana Matar,Seham Skah,Liza E B Moltu et al. Sittana Matar et al.
Purpose: Despite the clinical success of anti-CD20 monoclonal antibodies (mAbs) such as rituximab in the treatment of B-cell lymphoma, therapeutic resistance and relapse remain significant challenges, particularly in tumo...
Alina Drzyzga,Justyna Czapla,Tomasz Cichoń et al. Alina Drzyzga et al.
Introduction: The stimulator of interferon genes (STING) pathway has emerged as a promising target for cancer immunotherapy. Tumor-associated neutrophils (TANs) are underrated among the cells involved in STING-targeted th...
Sylwia A Stefańczyk,Xenija Kaiser,Ilona Hagelstein et al. Sylwia A Stefańczyk et al.
Background & aims: Colorectal cancer (CRC) represents a major global health burden due to its high incidence and mortality, particularly in the advanced stages, with limited treatment options. While therapies that block t...
Xinyu Yang,Sen Huang,Yuxin Wang et al. Xinyu Yang et al.
Purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Progressive loss of motor neuron function and disruption of the blood-brain barrier are key features of ALS. Under the influence of chemok...